Telmisartan Intermedia CAS 152628-02-9 Puritas >99.0% (HPLC) Factory
Ruifu Chemical Supple Telmisartan intermedia Cum Puritate
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl) Acidum benzoicum CAS 7148-03-0
Telmisartan Benzimidazole Acidum CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Nomen chemicum | 2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl) |
Synonyma | 1,7'-Dimethyl-2'-Propyl-2,5'-Bibenzimidazole;4-Methyl-6-(1-Methylbenzimidazol-2-yl)-2-Propylbenzimidazole;Telmisartan Related Compone A USP;Telmisartan EP |
CAS Number | 152628-02-9 |
CATTUS Number | RF-PI1882 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C19H20N4 |
M. Pondus | 304.40 |
Liquescens punctum | 1300~ 135.0℃ |
Density | 1.23±0.10 g/cm3 |
Solubilitas | Solutum in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-White ad lux Yellow Crystalline pulveris |
Solubilitas | Solutio munda sine praecipitate |
Aqua Content (KF) | <6.50% |
Cinere sulphated | <0.30% |
Substantiae cognatae | |
Omnis immunditia | <0.50% |
Totalis immunditias | <1.00% |
Incassum (By Chemical) | >99.0% (In Siccata Basis) |
Infrared Imaginis | Conformat ut Structure |
NMR | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Telmisartanum (CAS: 144701-48-4) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole (CAS: 152628-01-8) medium est Telmisartan (CAS: 144701-48-4).Telmisartan est receptor angiotensin II hypertensionem tractaturus.Maxime sanguinem pressura triste medicinae nunc maximum effectum 10 horarum habent.Telmisartan medicamentum sui generis potentissimum est.Acta studia ostendimus Telmisartan sanguinem pressuram 24 horarum die reducere posse, incluso primo mane, cum morbus cardiovascularis in summo periculo est.Telmisartan etiam nunc unicum genus angiotensin obstructorum receptarum, confirmatum ab investigatione clinica praeter altum sanguinem pressuram patientibus cum periculo cardiovasculari et diabete aegroti, potest etiam praesidium cardiovasculares praebere, eorum mortem ob morbum cardiovascularem, myocardialem infarctionem vel mortem reducere. ictum.